Journal of Clinical and Preventive Cardiology

EDITOR«SQ»S PAGE
Year
: 2021  |  Volume : 10  |  Issue : 3  |  Page : 79-

Editor's Page July 2021


Ravi R Kasliwal 
 Editor-in-Chief, Journal of Clinical and Preventive Cardiology, Gurugram, Haryana, India

Correspondence Address:
Dr. Ravi R Kasliwal
Adjunct Professor Cardiology (NBE), Chairman, Clinical and Preventive Cardiology, Medanta . The Medicity, Sector 38, Gurugram - 122 001, Haryana
India




How to cite this article:
Kasliwal RR. Editor's Page July 2021.J Clin Prev Cardiol 2021;10:79-79


How to cite this URL:
Kasliwal RR. Editor's Page July 2021. J Clin Prev Cardiol [serial online] 2021 [cited 2021 Dec 3 ];10:79-79
Available from: https://www.jcpconline.org/text.asp?2021/10/3/79/326477


Full Text



As I write this edition's Editor's Page, two distinct thoughts strike me: One - the waning of the second wave of coronavirus disease 2019 (COVID-19) and the devastation it wrought on humankind across the planet. It brings different thoughts to different people on different days, but one thing is clear - nobody wants a third wave. And two- the coming of the rains has brought some relief, but a lot of devastation to our country and our fellow citizens. Hopefully, tomorrow is another day!

The first article from Karnataka, titled “Clopidogrel resistance in cardiovascular disease patients and its association with gene polymorphisms: A pilot study” and authored by S Parameshwara and colleagues has long-term implications for postintervention patients who are advised dual-antiplatelet therapy. It is a thought-provoking article.

The second article brings forth a simmering problem that of stress among the healthcare professionals and importantly its mitigation. It has important implications and should be discussed and debated at length. It is titled “The prevalence, causes and management strategies for stress among healthcare professionals of Delhi-National Capital Region” and is authored by Rahul Mehrotra and colleagues.

The third article “Coronary collateral circulation in acute, subacute, and chronic total occlusions” from Puducherry discusses coronary collateral circulation and is a must read because it has wide implications for left ventricular function. It also emphasizes the value of syntax score. This article is a very informative read for those pursuing cardiology training.

Article four “Prevalence of anemia and iron deficiency among patients with heart failure admitted in a tertiary care hospital of Sub-Himalayan Region in North India” reminds us about some of the ignored medical aspects in patients of heart failure (HF). Even though this was a small hospital-based observational study, it does give an important message and I quote “hemogram and iron profile should be included in the investigational protocol during management of HF in Indian patients” unquote.

The fifth contribution “Comparison of global registry of acute coronary events and thrombolysis in myocardial infarction risk scores in non-ST-elevation acute coronary syndrome” by Satyanarayan Routray and colleagues is a timely reminder of going back to roots while treating patients of non-ST-elevation acute coronary syndrome.

The sixth article, which is a review article “The association between non-alcoholic fatty liver disease and cardiovascular disease: A window of opportunity” by Narendra S Choudhary and colleagues, is a wakeup call that in many areas of medicine, scientific and clinical collaboration is so important for the benefit of the patients. Between nonalcoholic fatty liver disease and cardiovascular disease prevention, there are huge windows of preventive opportunities.

The last article is a case report “Left-sided anomalous origin of the coronary artery from the opposite sinus: Single anomalous left anterior descending artery originating from the right coronary artery - A rare case” authored by Ashida T Sarojadevi and colleagues. is an interesting read.

In conclusion, dear readers, the coming months will be dominated by economy, COVID-appropriate behavior, and increase in cardiovascular disease burden. At the same time, the scientific journey continues…